Area of research
Infectious Diseases · Surgery
Research interest
Research interests include Kawasaki Disease and Coronary Complications, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, and Long-Term Effects of COVID-19.
Social Determinants of Health and Pediatric Long COVID in the US
Characterizing Long COVID Symptoms During Early Childhood
Characterizing Long COVID in Children and Adolescents
Molecular mimicry in multisystem inflammatory syndrome in children
Researching COVID to enhance recovery (RECOVER) pediatric study protocol: Rationale, objectives and design
Infants Admitted to US Intensive Care Units for RSV Infection During the 2022 Seasonal Peak
Extracorporeal Membrane Oxygenation Characteristics and Outcomes in Children and Adolescents With COVID-19 or Multisystem Inflammatory Syndrome Admitted to U.S. ICUs*
Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants
Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C
Health Impairments in Children and Adolescents After Hospitalization for Acute COVID-19 or MIS-C
NFKB2 haploinsufficiency identified via screening for IFN-α2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2–related complications
Measurement of Severe Acute Respiratory Syndrome Coronavirus 2 Antigens in Plasma of Pediatric Patients With Acute Coronavirus Disease 2019 or Multisystem Inflammatory Syndrome in Children Using an Ultrasensitive and Quantitative Immunoassay
Characterization and Outcomes of Hospitalized Children With Coronavirus Disease 2019: A Report From a Multicenter, Viral Infection and Respiratory Illness Universal Study (Coronavirus Disease 2019) Registry.
Changes in Distribution of Severe Neurologic Involvement in US Pediatric Inpatients With COVID-19 or Multisystem Inflammatory Syndrome in Children in 2021 vs 2020
Life-Threatening Complications of Influenza vs Coronavirus Disease 2019 (COVID-19) in US Children
Gastrointestinal Manifestations in Hospitalized Children With Acute SARS-CoV-2 Infection and Multisystem Inflammatory Condition: An Analysis of the VIRUS COVID-19 Registry
Association of Asthma With Treatments and Outcomes in Children With Critical Influenza
Tachyarrhythmias During Hospitalization for COVID‐19 or Multisystem Inflammatory Syndrome in Children and Adolescents
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome
Multisystem Inflammatory Syndrome in Children — Initial Therapy and Outcomes
Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12–18 Years — United States, June–September 2021
Vaccine Effectiveness Against Life-Threatening Influenza Illness in US Children
Characterization and Outcomes of Hospitalized Children With Coronavirus Disease 2019: A Report From a Multicenter, Viral Infection and Respiratory Illness Universal Study (Coronavirus Disease 2019) Registry
Data-driven clustering identifies features distinguishing multisystem inflammatory syndrome from acute COVID-19 in children and adolescents
Exuberant fibroblast activity compromises lung function via ADAMTS4
Association Between Elevated RBC Distribution Width and Multiple Organ Dysfunction in Pediatric Critical Illness
1690: RED BLOOD CELL DISTRIBUTION WIDTH VALUES PREDICT MULTIORGAN FAILURE IN CHILDREN ADMITTED TO THE PICU